Loading data for XCUR — first visit, this takes a few seconds.

Exicure, Inc.

NasdaqCM: XCUR · Real-Time Price · USD
1.25
-0.01 (-0.79%)
At close: Sep 09, 2026, 8:00 PM
1.41
-1.40%
After-hours: 6:54 PM

The price, the headline numbers and the latest news, in one place.

Exicure, Inc. (XCUR) Stock Price, Analysis & Data

No data available

Bid1.78
Market Cap9.36M
Revenue (ttm)n/a
Net Income (ttm)-8.28M
3.62
-1.31
n/a
-1.86
P/B (ttm)4.35
P/S (ttm)0.00
Earnings Daten/a
Ask1.71
Volume16,544
Avg. Volume (20D)413,177
Open1.23
Previous Close1.26
Day's Range1.23 - 1.28
52-Week Range1.05 - 9.48
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About XCUR

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California....

Industry Biotechnology
Sector Healthcare
IPO Date May 22, 2018
Employees 1
Stock Exchange NasdaqCM
Ticker Symbol XCUR
Full Company Profile

Financial Performance

In 2025, Exicure's revenue was 0, a decrease of -100% compared to the previous year's 500K. Earnings were -4.95M, a decrease of -49.02%.

Financial Statements

Earnings Surprise

Exicure has released their quarterly earnings on Aug 15, 2022:
  • Revenue of $0 misses estimates by $0, with NaN% YoY growth.
  • EPS of -8.3 misses estimates by -2.30, with 65.42% YoY growth.
No News article available yet